Divalproex Sodium Extended-Release is a Oral Tablet, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Contract Pharmacy Services-pa. The primary component is Divalproex Sodium.
| Product ID | 67046-143_5a04842a-c10b-83ac-e053-2991aa0a0a42 |
| NDC | 67046-143 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Divalproex Sodium Extended-Release |
| Generic Name | Divalproex Sodium |
| Dosage Form | Tablet, Extended Release |
| Route of Administration | ORAL |
| Marketing Start Date | 2017-09-25 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA078445 |
| Labeler Name | Contract Pharmacy Services-PA |
| Substance Name | DIVALPROEX SODIUM |
| Active Ingredient Strength | 500 mg/1 |
| Pharm Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2017-09-25 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA078445 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2017-09-25 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA078445 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2017-09-25 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA078445 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2017-09-25 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA078445 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2017-09-25 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA078445 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2017-09-25 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA078445 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2017-09-25 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA078445 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2017-09-25 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA078445 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2017-09-25 |
| Inactivation Date | 2020-01-31 |
| Ingredient | Strength |
|---|---|
| DIVALPROEX SODIUM | 500 mg/1 |
| SPL SET ID: | 5a04842a-c10a-83ac-e053-2991aa0a0a42 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 53808-1061 | Divalproex Sodium Extended-Release | Divalproex Sodium Extended-Release |
| 64725-0314 | Divalproex Sodium Extended-Release | Divalproex Sodium Extended-Release |
| 64725-0315 | Divalproex Sodium Extended-Release | Divalproex Sodium Extended-Release |
| 67046-143 | Divalproex Sodium Extended-Release | Divalproex Sodium Extended-Release |
| 0074-3826 | Depakote | Divalproex Sodium |
| 0074-6114 | Depakote | Divalproex Sodium |
| 0074-6212 | Depakote | Divalproex Sodium |
| 0074-6214 | Depakote | Divalproex Sodium |
| 0074-6215 | Depakote | Divalproex Sodium |
| 0074-7126 | Depakote | Divalproex Sodium |